Poseida Therapeutics (NASDAQ:PSTX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Poseida Therapeutics (PSTX) operate in?

Poseida Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Poseida Therapeutics Stock (NASDAQ: PSTX) stock price, news, charts, stock research, profile.

Open	$2.76
Close	-
Volume / Avg.	236.63K / 479.86K
Day Range	$2.70 - $2.98
52 Wk Range	1.87 - 4.27
Market Cap	$263.16M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	6.23%
Days to Cover	11.09

Recent News

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients. Mesoblast shares jumped 13.4% to $2.4399 on Monday.

Avi Kapoor

EQT, Genie Energy And Other Big Stocks Moving Lower On Monday

U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday.

Avi Kapoor

Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical Trial

Poseida Therapeutics Inc (NASDAQ: PSTX) released early efficacy and safety results from its Phase 1 study of P-BCMA-ALLO1, its BCMA-targeted allogeneic, T stem cell memory (TSCM)-rich chimeric antigen receptor

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jul

Aug

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.76
Close	-
Volume / Avg.	236.63K / 479.86K
Day Range	$2.70 - $2.98
52 Wk Range	1.87 - 4.27
Market Cap	$263.16M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	6.23%
Days to Cover	11.09

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Poseida Therapeutics (PSTX) stock?

You can purchase shares of Poseida Therapeutics (NASDAQ:PSTX) through any online brokerage.

View our list of the best stock brokerages

Who are Poseida Therapeutics (PSTX) competitors?

Other companies in Poseida Therapeutics’s space includes: Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Zentalis Pharma (NASDAQ:ZNTL), Sage Therapeutics (NASDAQ:SAGE) and Fate Therapeutics (NASDAQ:FATE).

What is the forecast, or price target, for Poseida Therapeutics (PSTX) stock?

Poseida Therapeutics has a consensus price target of $16.60.

What is the current price for Poseida Therapeutics (PSTX)?

The stock price for Poseida Therapeutics (NASDAQ: PSTX) is $2.705 last updated November 18, 2024 at 2:07 PM EST.

Does Poseida Therapeutics (PSTX) pay a dividend?

There are no upcoming dividends for Poseida Therapeutics.

When is Poseida Therapeutics (NASDAQ:PSTX) reporting earnings?

Poseida Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Is Poseida Therapeutics (PSTX) going to split?

There is no upcoming split for Poseida Therapeutics.

What sector and industry does Poseida Therapeutics (PSTX) operate in?

Poseida Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Poseida Therapeutics

Poseida Therapeutics (PSTX) Forecast